HK1232221A1 - 製備噁唑烷酮類的方法及含有噁唑烷酮類的組合物 - Google Patents
製備噁唑烷酮類的方法及含有噁唑烷酮類的組合物Info
- Publication number
- HK1232221A1 HK1232221A1 HK17105843.9A HK17105843A HK1232221A1 HK 1232221 A1 HK1232221 A1 HK 1232221A1 HK 17105843 A HK17105843 A HK 17105843A HK 1232221 A1 HK1232221 A1 HK 1232221A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- compositions containing
- oxazolidinones
- preparing
- preparing oxazolidinones
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10446908P | 2008-10-10 | 2008-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1232221A1 true HK1232221A1 (zh) | 2018-01-05 |
Family
ID=41382395
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15100600.5A HK1200169A1 (zh) | 2008-10-10 | 2015-01-19 | 用於合成噁唑烷酮的化合物 |
| HK17105843.9A HK1232221A1 (zh) | 2008-10-10 | 2017-06-13 | 製備噁唑烷酮類的方法及含有噁唑烷酮類的組合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15100600.5A HK1200169A1 (zh) | 2008-10-10 | 2015-01-19 | 用於合成噁唑烷酮的化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8604209B2 (zh) |
| EP (2) | EP2757104B1 (zh) |
| JP (1) | JP5773875B2 (zh) |
| KR (1) | KR101674146B1 (zh) |
| CN (2) | CN102177156B (zh) |
| AU (1) | AU2009303301B2 (zh) |
| CA (1) | CA2738671C (zh) |
| ES (2) | ES2748505T3 (zh) |
| HK (2) | HK1200169A1 (zh) |
| MX (2) | MX366793B (zh) |
| RU (2) | RU2659792C1 (zh) |
| SG (2) | SG10201702946RA (zh) |
| WO (1) | WO2010042887A2 (zh) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| MX366793B (es) | 2008-10-10 | 2019-07-24 | Merck Sharp & Dohme Corp Star | Metodos para preparar oxazolidinonas y composiciones que las contienen. |
| SG173497A1 (en) | 2009-02-03 | 2011-09-29 | Trius Therapeutics | Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate |
| US8580767B2 (en) * | 2009-05-28 | 2013-11-12 | Trius Therapeutics, Inc. | Oxazolidinone containing dimer compounds, compositions and methods to make and use |
| US20120065170A1 (en) | 2010-09-10 | 2012-03-15 | Micurx Pharmaceuticals, Inc. | Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections |
| WO2016009401A2 (en) * | 2014-07-18 | 2016-01-21 | Dr. Reddy's Laboratories Limited | Preparation of tedizolid phosphate |
| CN105367547B (zh) * | 2014-08-19 | 2019-04-23 | 北京桦冠生物技术有限公司 | 一种噁唑啉酮抗生素的新合成工艺 |
| CN104496979A (zh) * | 2014-09-17 | 2015-04-08 | 博瑞生物医药技术(苏州)有限公司 | 一种噁唑烷酮类化合物及其中间体的制备方法 |
| WO2016041505A1 (zh) * | 2014-09-17 | 2016-03-24 | 正大天晴药业集团股份有限公司 | 一种磷酸特地唑胺、其中间体以及它们的制备方法 |
| CN104327119A (zh) * | 2014-10-17 | 2015-02-04 | 苏州明锐医药科技有限公司 | 磷酸泰地唑胺的制备方法 |
| WO2016088100A1 (en) * | 2014-12-05 | 2016-06-09 | Sun Pharmaceutical Industries Limited | Processes for the preparation of tedizolid phosphate and its intermediates |
| WO2016088101A1 (en) * | 2014-12-05 | 2016-06-09 | Sun Pharmaceutical Industries Limited | Processes for the preparation of tedizolid phosphate and its intermediates |
| WO2016088102A1 (en) * | 2014-12-05 | 2016-06-09 | Sun Pharmaceutical Industries Limited | Processes for the preparation of tedizolid phosphate and its intermediates |
| WO2016088103A1 (en) * | 2014-12-05 | 2016-06-09 | Sun Pharmaceutical Industries Limited | A process for the preparation of tedizolid phosphate |
| CN104558034A (zh) * | 2015-01-21 | 2015-04-29 | 齐鲁制药有限公司 | 磷酸特地唑胺二钠盐的新晶型及其制备方法 |
| CN105837634B (zh) * | 2015-01-30 | 2020-09-04 | 上海创诺制药有限公司 | 一种泰地唑胺磷酸酯结晶体及其制备方法 |
| CN104592218B (zh) * | 2015-02-13 | 2015-11-04 | 江苏欧信医药化工有限公司 | 一种泰地唑胺的合成方法 |
| CN104892592A (zh) * | 2015-03-30 | 2015-09-09 | 成都惟新医药科技有限公司 | 一种泰地唑胺的制备方法 |
| CN106146485B (zh) * | 2015-04-01 | 2021-04-30 | 上海迪赛诺化学制药有限公司 | 一种制备泰地唑胺的方法及其得到的泰地唑胺结晶体 |
| CN106279281B (zh) * | 2015-05-15 | 2018-08-03 | 重庆圣华曦药业股份有限公司 | 噁唑烷酮类抗菌素泰地唑胺磷酸酯的精制方法 |
| CN106279282B (zh) * | 2015-05-21 | 2019-08-23 | 博瑞生物医药（苏州）股份有限公司 | 一种磷酸特地唑胺的纯化方法 |
| CN106317114B (zh) * | 2015-07-02 | 2018-11-20 | 南京优科制药有限公司 | 一种磷酸特地唑胺的制备方法 |
| CN105131037B (zh) * | 2015-07-28 | 2017-05-03 | 济南爱思医药科技有限公司 | 一种高纯度泰地唑胺磷酸酯的制备方法 |
| CN106632298B (zh) * | 2015-11-03 | 2021-06-01 | 上海科胜药物研发有限公司 | 一种泰地唑胺的制备方法及其中间体 |
| KR101855334B1 (ko) * | 2015-12-11 | 2018-06-08 | 에스티팜 주식회사 | 옥사졸리디논 유도체의 중간체 제조방법 |
| CN105418681A (zh) * | 2015-12-15 | 2016-03-23 | 南京艾德凯腾生物医药有限责任公司 | 一种磷酸特地唑胺的制备方法 |
| CN107488188B (zh) * | 2016-06-12 | 2019-03-15 | 重庆圣华曦药业股份有限公司 | 一种制备特地唑胺关键中间体的合成方法 |
| CN106146560B (zh) * | 2016-07-12 | 2019-02-01 | 扬子江药业集团有限公司 | 一种高纯度磷酸特地唑胺的精制方法 |
| CN106432182B (zh) * | 2016-09-06 | 2019-04-30 | 铜仁学院 | 特地唑胺中间体的合成方法 |
| CN106565680A (zh) * | 2016-10-31 | 2017-04-19 | 瑞阳制药有限公司 | 特地唑胺杂质及其制备方法 |
| CN108059624A (zh) * | 2016-11-08 | 2018-05-22 | 上海医药工业研究院 | 用于制备咔哒唑胺关键中间体的制备方法 |
| CN106632240A (zh) * | 2016-11-25 | 2017-05-10 | 山东轩德医药科技有限公司 | 一种2‑甲基‑5‑(5‑溴吡啶‑2‑基)四氮唑的制备方法 |
| CN106699730A (zh) * | 2016-12-23 | 2017-05-24 | 山东轩德医药科技有限公司 | 2‑甲基‑5‑(5‑溴吡啶‑2‑基)四氮唑的制备方法 |
| CN107722056A (zh) * | 2017-10-31 | 2018-02-23 | 重庆华邦胜凯制药有限公司 | 磷酸特地唑胺的制备方法 |
| US11452719B2 (en) | 2017-12-13 | 2022-09-27 | Merck Sharp & Dohme Llc | Pharmaceutical compositions of tedizolid phosphate |
| CN110804038B (zh) * | 2018-08-06 | 2021-03-05 | 上海博志研新药物技术有限公司 | 磷酸特地唑胺及其中间体的制备方法 |
| CN110938058B (zh) * | 2018-09-22 | 2022-04-12 | 南京优科生物医药研究有限公司 | 一种噁唑烷酮类抗生素中间体的制备方法 |
| CN111116652A (zh) * | 2019-12-06 | 2020-05-08 | 山东中医药大学 | 一种高纯度磷酸特地唑胺的制备方法 |
| CN113121518B (zh) * | 2019-12-31 | 2022-06-28 | 北京福元医药股份有限公司 | 一种特地唑胺杂质的制备方法 |
| CN111285848A (zh) * | 2020-04-10 | 2020-06-16 | 苏州敬业医药化工有限公司 | 一种5-溴-2-(2-甲基-2h-四唑-5-基)吡啶的纯化方法 |
| IL299155A (en) | 2020-06-18 | 2023-02-01 | Akagera Medicines Inc | Oxazolidinone compounds, liposome preparations containing oxazolidinone compounds and methods of using them |
| CN114105946A (zh) * | 2020-08-26 | 2022-03-01 | 浙江苏泊尔制药有限公司 | 一种磷酸特地唑胺中间体及其制备方法 |
| CN112961186A (zh) * | 2021-02-04 | 2021-06-15 | 海南通用康力制药有限公司 | 一种磷酸特地唑胺的纯化方法 |
| CN113248471B (zh) * | 2021-07-05 | 2021-09-21 | 南京桦冠生物技术有限公司 | 一种唑胺类药物中间体的制备方法及其中间体 |
| CN113488445A (zh) * | 2021-07-05 | 2021-10-08 | 合肥巨一动力系统有限公司 | 一种igbt封装散热结构及其应用的电机控制器 |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU80081A1 (fr) * | 1977-08-26 | 1979-05-15 | Delalande Sa | Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique |
| US4128654A (en) * | 1978-02-10 | 1978-12-05 | E. I. Du Pont De Nemours And Company | 5-Halomethyl-3-phenyl-2-oxazolidinones |
| US4340606A (en) | 1980-10-23 | 1982-07-20 | E. I. Du Pont De Nemours And Company | 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents |
| FR2500450A1 (fr) * | 1981-02-25 | 1982-08-27 | Delalande Sa | Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique |
| US4461773A (en) * | 1982-09-15 | 1984-07-24 | E. I. Dupont De Nemours And Company | P-Oxooxazolidinylbenzene compounds as antibacterial agents |
| CA1320730C (en) | 1987-10-16 | 1993-07-27 | The Du Pont Merck Pharmaceutical Company | Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents |
| US4948801A (en) * | 1988-07-29 | 1990-08-14 | E. I. Du Pont De Nemours And Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
| DE69216251T2 (de) * | 1991-11-01 | 1997-05-15 | Pharmacia & Upjohn Co., Kalamazoo, Mich. | Substituierte aryl- und heteroaryl-phenyloxazolidinone |
| SK283420B6 (sk) | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| NZ257031A (en) * | 1992-12-08 | 1996-07-26 | Upjohn Co | Tropone substituted phenyloxazolidinone derivatives and anti-bacterial medicaments thereof |
| US5688792A (en) * | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| KR100312903B1 (ko) | 1993-11-22 | 2002-02-28 | 로렌스 티. 마이젠헬더 | 치환된-하이드록시아세틸피페라진페닐옥사졸리디논의에스테르 |
| GB9702213D0 (en) * | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
| US6413981B1 (en) | 1999-08-12 | 2002-07-02 | Ortho-Mcneil Pharamceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| GB0009803D0 (en) * | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| MXPA02012045A (es) | 2000-06-05 | 2003-10-15 | Dong A Pharm Co Ltd | Nuevos derivados de oxazolidinona y proceso para su preparacion. |
| US20020115669A1 (en) * | 2000-08-31 | 2002-08-22 | Wiedeman Paul E. | Oxazolidinone chemotherapeutic agents |
| WO2002081470A1 (en) | 2001-04-07 | 2002-10-17 | Astrazeneca Ab | Oxazolidinones containing a sulfonimid group as antibiotics |
| US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
| PL369183A1 (en) * | 2001-09-11 | 2005-04-18 | Astrazeneca Ab | Oxazolidinone and/or isoxazoline as antibacterial agents |
| JP2005519870A (ja) | 2001-10-25 | 2005-07-07 | アストラゼネカ アクチボラグ | 抗菌活性をもつアリール置換オキサゾリジノン類 |
| NZ515881A (en) | 2001-12-03 | 2004-09-24 | New Zealand Dairy Board | Cheese flavour ingredient and method of its production |
| CN1653064A (zh) | 2002-02-28 | 2005-08-10 | 阿斯特拉曾尼卡有限公司 | 噁唑烷酮衍生物、其制备方法以及包含它们的药用组合物 |
| CA2477344A1 (en) * | 2002-02-28 | 2003-09-04 | Astrazeneca Ab | 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents |
| US7223870B2 (en) | 2002-11-01 | 2007-05-29 | Pfizer Inc. | Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction |
| CA2507628A1 (en) | 2002-11-28 | 2004-06-10 | Astrazeneca Ab | Oxazolidinones as antibacterial agents |
| AU2003302404B2 (en) * | 2002-11-28 | 2008-06-19 | Astrazeneca Ab | Oxazolidinone and / or isoxazoline derivatives as antibacterial agents |
| GB0229518D0 (en) * | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
| US7144911B2 (en) * | 2002-12-31 | 2006-12-05 | Deciphera Pharmaceuticals Llc | Anti-inflammatory medicaments |
| US7202257B2 (en) * | 2003-12-24 | 2007-04-10 | Deciphera Pharmaceuticals, Llc | Anti-inflammatory medicaments |
| TW200500360A (en) * | 2003-03-01 | 2005-01-01 | Astrazeneca Ab | Hydroxymethyl compounds |
| GB0306358D0 (en) * | 2003-03-20 | 2003-04-23 | Astrazeneca Ab | Chemical compounds |
| BRPI0411688A (pt) * | 2003-07-02 | 2006-12-26 | Merck & Co Inc | antibióticos de oxazolidinona substituìda de grupo de ciclopropil e seus derivados |
| JP2007521283A (ja) * | 2003-07-02 | 2007-08-02 | メルク アンド カンパニー インコーポレーテッド | シクロプロピル基で置換されたオキサゾリジノン系抗生物質およびその誘導体 |
| WO2005051933A1 (en) * | 2003-11-28 | 2005-06-09 | Ranbaxy Laboratories Limited | An improved process for the synthesis of 4-(4-benzyloxy-carbonylamino-2-fluorophenyl)-piperazine-1-carboxylic acid tert-butyl ester, a key intermediate for oxazolidinone antimicrobials and compounds prepared thereby |
| WO2005061468A1 (en) * | 2003-12-17 | 2005-07-07 | Rib-X Pharmaceuticals, Inc. | Halogenated biaryl heterocyclic compounds and methods of making and using the same |
| KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| US20070191336A1 (en) * | 2003-12-24 | 2007-08-16 | Flynn Daniel L | Anti-inflammatory medicaments |
| US20080021012A1 (en) * | 2004-05-25 | 2008-01-24 | Astrazeneca Ab | 3-[4-{6-Substituted Alkanoyl Pyridin-3-Yl}-3-Phenyl]-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones As Antibacterial Agents |
| US20080064689A1 (en) | 2004-05-25 | 2008-03-13 | Astrazeneca Ab | 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents |
| GB0411596D0 (en) | 2004-05-25 | 2004-06-30 | Astrazeneca Ab | Chemical process |
| EP1753755A1 (en) | 2004-05-25 | 2007-02-21 | AstraZeneca AB | 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents |
| WO2005116024A1 (en) * | 2004-05-25 | 2005-12-08 | Astrazeneca Ab | 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections |
| US20100286211A1 (en) | 2004-10-08 | 2010-11-11 | Biswajit Das | Oxazolidinone derivatives as antimicrobials |
| US20090018123A1 (en) | 2005-06-20 | 2009-01-15 | Milind D Sindkhedkar | Oxazolidinones Bearing Antimicrobial Activity Composition and Methods of Preparation |
| WO2007138381A2 (en) | 2005-10-14 | 2007-12-06 | Targanta Therapeutics Inc. | Phosphonated oxazolidinones and uses thereof for the prevention and treatment of bone and joint infections |
| EP2185549B1 (en) | 2007-08-06 | 2018-10-03 | Micurx Pharmaceuticals, Inc. | Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections |
| MX366793B (es) | 2008-10-10 | 2019-07-24 | Merck Sharp & Dohme Corp Star | Metodos para preparar oxazolidinonas y composiciones que las contienen. |
| SG173497A1 (en) | 2009-02-03 | 2011-09-29 | Trius Therapeutics | Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate |
| US8580767B2 (en) | 2009-05-28 | 2013-11-12 | Trius Therapeutics, Inc. | Oxazolidinone containing dimer compounds, compositions and methods to make and use |
-
2009
- 2009-10-09 MX MX2014004600A patent/MX366793B/es unknown
- 2009-10-09 EP EP14159112.3A patent/EP2757104B1/en active Active
- 2009-10-09 ES ES09749235T patent/ES2748505T3/es active Active
- 2009-10-09 AU AU2009303301A patent/AU2009303301B2/en active Active
- 2009-10-09 CN CN200980140144.4A patent/CN102177156B/zh active Active
- 2009-10-09 JP JP2011531233A patent/JP5773875B2/ja active Active
- 2009-10-09 ES ES14159112T patent/ES2744907T3/es active Active
- 2009-10-09 KR KR1020117010217A patent/KR101674146B1/ko active IP Right Grant
- 2009-10-09 SG SG10201702946RA patent/SG10201702946RA/en unknown
- 2009-10-09 RU RU2015122033A patent/RU2659792C1/ru active
- 2009-10-09 US US12/577,089 patent/US8604209B2/en active Active
- 2009-10-09 WO PCT/US2009/060267 patent/WO2010042887A2/en active Application Filing
- 2009-10-09 CA CA2738671A patent/CA2738671C/en active Active
- 2009-10-09 EP EP09749235.9A patent/EP2346858B1/en active Active
- 2009-10-09 SG SG2013075965A patent/SG195544A1/en unknown
- 2009-10-09 RU RU2011115109/04A patent/RU2556234C2/ru active
- 2009-10-09 CN CN201610581761.XA patent/CN106220621B/zh active Active
- 2009-10-09 MX MX2011003820A patent/MX2011003820A/es active IP Right Grant
-
2013
- 2013-11-25 US US14/089,050 patent/US9328087B2/en active Active
-
2015
- 2015-01-19 HK HK15100600.5A patent/HK1200169A1/zh unknown
-
2017
- 2017-06-13 HK HK17105843.9A patent/HK1232221A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010042887A3 (en) | 2010-06-24 |
| JP5773875B2 (ja) | 2015-09-02 |
| CN102177156B (zh) | 2016-08-24 |
| EP2346858B1 (en) | 2019-08-07 |
| AU2009303301B2 (en) | 2014-09-11 |
| AU2009303301A1 (en) | 2010-04-15 |
| US8604209B2 (en) | 2013-12-10 |
| CN106220621B (zh) | 2019-06-11 |
| HK1200169A1 (zh) | 2015-07-31 |
| SG195544A1 (en) | 2013-12-30 |
| ES2744907T3 (es) | 2020-02-26 |
| WO2010042887A2 (en) | 2010-04-15 |
| MX2011003820A (es) | 2011-06-16 |
| KR20110071107A (ko) | 2011-06-28 |
| ES2748505T3 (es) | 2020-03-17 |
| US20140206878A1 (en) | 2014-07-24 |
| RU2556234C2 (ru) | 2015-07-10 |
| JP2012505252A (ja) | 2012-03-01 |
| KR101674146B1 (ko) | 2016-11-08 |
| RU2659792C1 (ru) | 2018-07-04 |
| EP2346858A2 (en) | 2011-07-27 |
| CN106220621A (zh) | 2016-12-14 |
| CA2738671C (en) | 2018-05-01 |
| EP2757104A1 (en) | 2014-07-23 |
| MX366793B (es) | 2019-07-24 |
| RU2011115109A (ru) | 2012-11-20 |
| EP2757104B1 (en) | 2019-08-14 |
| US20100093669A1 (en) | 2010-04-15 |
| SG10201702946RA (en) | 2017-05-30 |
| CA2738671A1 (en) | 2010-05-15 |
| CN102177156A (zh) | 2011-09-07 |
| US9328087B2 (en) | 2016-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1232221A1 (zh) | 製備噁唑烷酮類的方法及含有噁唑烷酮類的組合物 | |
| ZA201006944B (en) | Compositions and methods for preparing and using same | |
| IL228897A0 (en) | Stable antibody preparations and methods for their stabilization | |
| SI3812360T1 (sl) | Monoklorotrifluoropropenske spojine in sestavki ter postopki, ki jih uporabljajo | |
| IL210153A0 (en) | Nutrigenomics methods and compositions | |
| IL212822A0 (en) | Anti-cxcr1 compositions and methods | |
| GB0819530D0 (en) | Methods and compositions | |
| IL208445A0 (en) | Compositions and methods for immunotherapy | |
| IL210559A0 (en) | Novel compositions and methods | |
| IL210588A0 (en) | Novel compositions and methods | |
| EP2285405A4 (en) | VACCINE COMPOSITIONS AND METHODS | |
| GB0817585D0 (en) | Novel compositions and methods | |
| PL2294198T3 (pl) | Sposoby i kompozycje do ulepszania roślin | |
| IL214211A0 (en) | Stable vaccine compositions and methods for preparing the same | |
| GB0811250D0 (en) | Methods and compositions | |
| GB0801122D0 (en) | Vaccine composition | |
| EP2516649A4 (en) | NOVEL PNEUMOVIRUS COMPOSITIONS AND METHODS OF USE | |
| AU2008905185A0 (en) | Methods and compositions for preparing hormone-depleted surem | |
| EP2496593A4 (en) | AMPHIPHILIC COMPOSITIONS AND PREPARATION METHODS USING THE SAME | |
| GB0802326D0 (en) | Vaccine Composition | |
| GB0816534D0 (en) | Compositions and methods | |
| GB0811152D0 (en) | Methods and compositions | |
| GB0818399D0 (en) | Methods and compositions | |
| GB0803464D0 (en) | Methods and compositions | |
| GB0812479D0 (en) | Composition for reducing hair growth |